|
Communicating Awareness of (NSAIDs) Risk Effectively (CARE) - Part I
Certified for 1 AMA PRA Category 1 Credit™
Presented by the University of Alabama School of Medicine
Division of Continuing Medical Education
| Release Date: October 28, 2008 |
Expiration Date: October 28, 2011 |
CME Information
Target Audience:
Primary care physicians
Objectives:
Upon completion of this CME activity, participants should be able to:
- Describe the incidence of NSAID-related GI complications.
- Recognize the gastrointestinal ulceration, bleeding, or perforation risks associated with use of NSAIDs.
- Recognize the importance of GI prophylaxis in high-risk populations using NSAIDs.
- Describe the racial differences in patient reports of being informed by their physicians about NSAID-related risks.
- Discuss the importance of culturally sensitive care in preventing NSAID-related adverse events.
- Describe two reasons why cultural competency is an important factor in the patient-provider encounter.
Source:
Author:
Monica Crawford, MD
Assistant Professor of Medicine
Department of Immunology/Rheumatology
University of Alabama School of Medicine, UAB
Birmingham, Alabama
Co-Editors:
Jeroan J. Allison, MD, MS
Katie Crenshaw, JD, MSEd
Carlos Estrada, MD, MS
Trudi Horton, PhD
Michael Schoen, PhD
University of Alabama School of Medicine, Division of CME
Disclosure:
Dr. Crawford has disclosed an honorarium from Pfizer. Ms. Crenshaw, Dr. Horton, and Dr. Schoen have disclosed receipt of grant funding from Pfizer. The UAB Division of CME has implemented its mechanism to resolve this potential conflict of interest by validating the content contained herein. Drs. Allison and Estrada have no commercial affiliations to disclose.
This educational initiative is supported through an unrestricted educational grant from Pfizer, Inc.
Because of the nature of preliminary studies, some products mentioned are unlabeled and investigational. Dosages, indications, and methods of use of drugs mentioned in this publication may reflect the experience of the authors, clinical literature, or other resources. Therefore, please see the full prescribing information before using any licensed product mentioned.
CME Participation:
To participate in this online course for CME credit, please review the objectives before beginning the program. Complete the course and the self-assessment test before October 28, 2011 to receive CME credit. Your certificate will then be available online. This process should take approximately 1 hour.
Accreditation:
The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.
Disclaimer:
Dosages, indications, and methods of use of any drug referred to in this publication may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned. UAB is an equal opportunity/affirmative action institution.
Course Introduction:
Non-steroidal anti-inflammatory drugs (NSAIDs) are some of the most commonly prescribed medications, but they frequently lead to adverse events. In addition, racial disparities exist in NSAIDs risk awareness, patient-doctor risk communication, and NSAIDs risk behavior. Provision of culturally competent care is one effective means of closing such health disparities and of delivering high-quality care to all patients.
The Division of Continuing Medical Education at UAB has developed a special series of three online courses focusing on effective strategies for discussing the risks and benefits of NSAIDs with patients from diverse backgrounds. These online courses were designed for primary care physicians and other healthcare professionals like you who aspire to excellence in all aspects of practice. Each online course is founded in scientific evidence and illustrates practical techniques you can apply immediately to your work.
Case 1:
Mrs. K is a 68-year-old African-American woman with hypertension, hyperlipidemia, obesity, and osteoarthritis of the knees. Her medications include hydrochlorothiazide, lisinopril, and simvastatin. In addition, she also takes low dose ASA because she heard this was good for her heart and ibuprofen OTC twice daily for knee pain.
She was born and raised in a rural southern US town where she has lived her entire life. She has a high school education and has worked as a housekeeper for almost 50 years. She lives with her husband with whom she had 5 children, and together they are now raising their 12-year-old grandson. Her annual household income is <$20,000 per year.
Mrs. K is somewhat mistrustful of the healthcare system. She grew up in the rural south during a time of overt racial discrimination, and as a young woman, she had several unpleasant experiences in medical and dental offices. She knows that much has changed since that time, but she still carries painful memories.
She presents today to Dr. Z because she recently joined a low-impact aerobics class at her church but is having difficulty keeping up due to knee pain. After reviewing the x-ray report of her knees from six months ago, Dr. Z informs her that she would benefit from an arthritis medication. He writes her a prescription for meloxicam 7.5mg per day.
|